Data analysis from the Spanish Registry of Cardiac Surgery (RECC) 2021-2024
The Spanish Cardiac Surgery Registry (RECC) is an essential tool for monitoring and analyzing cardiovascular surgical practice in Spain. Since its implementation in 2021 through the end of 2024, a total of 16631 procedures have been recorded, of which 14048 were major cardiac surgeries. The current...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Recursos: | Universitat de Lleida (UdL) |
| Repositorio: | Repositori Obert UdL |
| OAI Identifier: | oai:repositori.udl.cat:10459.1/469247 |
| Acesso em linha: | https://doi.org/10.1016/j.circv.2025.08.002 https://hdl.handle.net/10459.1/469247 |
| Access Level: | acceso abierto |
| Palavra-chave: | Cardiovascular surgery Acquired heart diseases Aortic surgery Coronary artery bypass surgery |
| Resumo: | The Spanish Cardiac Surgery Registry (RECC) is an essential tool for monitoring and analyzing cardiovascular surgical practice in Spain. Since its implementation in 2021 through the end of 2024, a total of 16631 procedures have been recorded, of which 14048 were major cardiac surgeries. The current analysis includes data from 23 centers that reported at least 40 procedures, representing a significant —though not exhaustive— sample of national activity. During 2024, the number of interventions included in the RECC increased by 81,7% compared to the previous year. The EuroSCORE II, with a mean of 5,4%, was used as a tool for preoperative risk stratification. Overall, it demonstrated good discriminative ability (AUC 0,787) in low-risk patients, although its performance was limited in specific subgroups such as coronary surgery, mitral valve replacement, tricuspid valve surgery, and aortic pathology. In terms of procedure distribution, valve surgery was the most common (53,0%), followed by isolated coronary surgery (25,4%) and aortic surgery (15,4%). The overall observed mortality was 5,1% (risk-adjusted mortality ratio, IMAR 0,94), rising slightly to 5,5% in 2024 (IMAR 1,08), although it remained below the mortality predicted by EuroSCORE II in most categories. |
|---|